CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
AFO to improve outcomesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02280200
NCT02280200N/ACompleted
CompareCT.gov

Efficacy of Ankle-Foot Orthoses on Walking Ability in Peripheral Artery Disease: The AFO for PAD Trial I

University of Minnesota·interventional·Posted Oct 31, 2014·Updated Jul 31, 2019

In Brief

A clinical study evaluating AFO to improve outcomes for Peripheral Artery Disease. Completed, enrolled 31 participants across 1 site.

Detailed Summary

The primary aim of this study is to investigate the effect of an ankle foot orthoses (AFO) on the primary outcome of peak walking time (PWT) in patients with peripheral artery disease (PAD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Artery Disease
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS)

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 31, 2014
Enrollment StartNov 1, 2014
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 11.7 years ago

Interventions

AFO to improve outcomesdevice

Ankle foot orthoses (AFO) are light-weight, low profile carbon fiber devices that store and release energy during ambulation. The AFO, in combination with standard of care advice to walk more, will be used to determine if there is any improvement in PAD patient outcomes.